Description: Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums. The company was formerly known as Jedediah Resources Corp. and changed its name to Alterola Biotech, Inc. in July 2010. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech, Inc. is a subsidiary of London Pharma Holdings Limited.
Home Page: alterola-abti.com/
47 Hamilton Square
Birkenhead,
CH41 5AR
United Kingdom
Phone:
44 1516 019 477
Officers
| Name | Title |
|---|---|
| Mr. Timothy Paul Rogers | Executive Chairman |
| Mr. David John Hitchcock O.B.E. | CEO & Director |
| Mr. Nathan Thompson | CFO, Secretary & Director |
| Mr. Colin G. Stott B.Sc. | COO & Director |
| Mr. Dominic Schiller | IP Counsel, Chief IP Officer & Director |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.522 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |